Jonathan E. Phillips

1.6k citations

42 papers · 1.2k indexed · h-index 16

Impact in

Pulmonary and Respiratory Medicine top 5%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inhalation and Respiratory Drug Delivery
- Neonatal Respiratory Health Research
- Respiratory and Cough-Related Research
Physiology top 10%
- Asthma and respiratory diseases

Papers in ⓘ

Physiology 19
- Asthma and respiratory diseases 18
Pulmonary and Respiratory Medicine 18
- Inhalation and Respiratory Drug Delivery 10
- Chronic Obstructive Pulmonary Disease (COPD) Research 8
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3

Co-authors: Jay S. Fine (7 shared papers)Richard W. Chapman (14 shared papers)R. William Hipkin (2 shared papers)Aidan K. Curran (3 shared papers)D J Lundell (1 shared paper)Donovan B. Yeates (3 shared papers)John A. Hey (5 shared papers)Christopher S. Stevenson (7 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)European Journal of Pharmacology (2 papers)Pharmacology & Therapeutics (2 papers)Pulmonary Pharmacology & Therapeutics (2 papers)Journal of Visualized Experiments (2 papers)
Partner nations: United States United Kingdom South Korea

In The Last Decade

Jonathan E. Phillips

40 papers receiving 1.2k citations

Peers

Countries citing papers authored by Jonathan E. Phillips

Since Specialization

Citations

This map shows the geographic impact of Jonathan E. Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Phillips more than expected).

Fields of papers citing papers by Jonathan E. Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan E. Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Phillips. The network helps show where Jonathan E. Phillips may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan E. Phillips, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan E. Phillips Line = papers co-authored together Jonathan E. Phillips links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CXCR2 antagonists for the treatment of pulmonary disease Pharmacology & Therapeutics ·Richard W. Chapman, Jonathan E. Phillips, R. William Hipkin, Aidan K. Curran, D J Lundell, Jay S. Fine	2008	171
2	Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease PLoS ONE ·Ruoqi Peng, Sriram Sridhar, Gaurav Tyagi, Jonathan E. Phillips, Rosario Garrido, Paul G. Harris, Lisa Burns, Lorena Renteria, John Woods, Leena Chen, John Allard, Palanikumar Ravindran, Hans Bitter, Zhenmin Liang, Cory M. Hogaboam, Chris Kitson, David C. Budd, Jay S. Fine, Carla M. T. Bauer, Christopher S. Stevenson	2013	164
3	A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation Journal of Pharmacology and Experimental Therapeutics ·Richard W. Chapman, Michael Minnicozzi, Chander Celly, Jonathan E. Phillips, Ted T. Kung, R. William Hipkin, Xuedong Fan, Diane Rindgen, Gregory Deno, Richard Bond, Waldemar Gonsiorek, Motasim Billah, Jay S. Fine, John A. Hey	2007	116
4	Assessment of Brd4 Inhibition in Idiopathic Pulmonary Fibrosis Lung Fibroblasts and in Vivo Models of Lung Fibrosis American Journal Of Pathology ·Xiaoyan Tang, Ruoqi Peng, Jonathan E. Phillips, Jeremy Deguzman, Yonglin Ren, Subramanium Apparsundaram, Qi Luo, Carla M. T. Bauer, María E. Fuentes, Julie A. DeMartino, Gaurav Tyagi, Rosario Garrido, Cory M. Hogaboam, Christopher P. Denton, Alan Holmes, Christopher Kitson, Christopher S. Stevenson, David C. Budd	2013	102
5	Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases Frontiers in Pharmacology ·Jonathan E. Phillips	2020	89
6	Regulation of vocal fold transepithelial water fluxes Journal of Applied Physiology ·Kimberly V. Fisher, Alvin Telser, Jonathan E. Phillips, Donovan B. Yeates	2001	51
7	Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPD Mucosal Immunology ·Pastor C. Harris, Sainetra Sridhar, Ruoqi Peng, Jonathan E. Phillips, Reinhold Cohn, Linda B. Burns, John Woods, Meera Ramanujam, Martine Loubeau, Gaurav Tyagi, John Allard, Michael E. Burczynski, Palanikumar Ravindran, Donavan T. Cheng, Hans Bitter, Jay S. Fine, Carla M. T. Bauer, Christopher S. Stevenson	2012	44
8	Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats European Journal of Pharmacology ·Richard W. Chapman, Aileen House, Howard Jones, J Richard, Chander Celly, D. B. Prelusky, Pauline C. Ting, John C. Hunter, James Lamca, Jonathan E. Phillips	2007	40
9	C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Jianhua Chao, Arthur G. Taveras, Jianping Chao, Cynthia Aki, Michael P. Dwyer, Younong Yu, Purakkattle Biju, Diane Rindgen, James Jakway, William Hipkin, James Fosetta, Xuedong Fan, Daniel Lundell, Jay S. Fine, Michael Minnicozzi, Jonathan E. Phillips, J. Robert Merritt	2007	38
10	Inhaled efficacious dose translation from rodent to human: A retrospective analysis of clinical standards for respiratory diseases Pharmacology & Therapeutics ·Jonathan E. Phillips	2017	35
11	Bleomycin induced lung fibrosis increases work of breathing in the mouse Pulmonary Pharmacology & Therapeutics ·Jonathan E. Phillips, Ruoqi Peng, Lisa Burns, Paul G. Harris, Rosario Garrido, Gaurav Tyagi, Jay S. Fine, Christopher S. Stevenson	2011	33
12	Antigen-induced mast cell expansion and bronchoconstriction in a mouse model of asthma American Journal of Physiology-Lung Cellular and Molecular Physiology ·Shannon Li, Minara Aliyeva, Nirav Daphtary, Rebecca Martin, Matthew E. Poynter, Shannon F. Kostin, Jos van der Velden, Alexandra M. Hyman, Christopher S. Stevenson, Jonathan E. Phillips, Lennart K. A. Lundblad	2013	33
13	Bidirectional Transepithelial Water Transport: Measurement and Governing Mechanisms Biophysical Journal ·Jonathan E. Phillips, Lid B. Wong, Donovan B. Yeates	1999	30
14	Tachykinin NK₃ and NK₁ receptor activation elicits secretion from porcine airway submucosal glands British Journal of Pharmacology ·Jonathan E. Phillips, John A. Hey, Michel R. Corboz	2003	29
15	Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration European Journal of Pharmacology ·Richard W. Chapman, Aileen House, J Richard, D. B. Prelusky, James Lamca, Peng Wang, Dan Lundell, Ping Wu, Pauline C. Ting, Joe F. Lee, Robert Aslanian, Jonathan E. Phillips	2010	21
16	Three-dimensional analysis of rodent paranasal sinus cavities from X-ray computed tomography (CT) scans. PubMed ·Jonathan E. Phillips, Lunan Ji, Maria A. Rivelli, Richard W. Chapman, Michel R. Corboz	2009	21
17	Steroidal C-21 mercapto derivatives as dissociated steroids: Discovery of an inhaled dissociated steroid Bioorganic & Medicinal Chemistry Letters ·Purakkattle Biju, Kevin D. McCormick, Robert Aslanian, Michael Berlin, Daniel H. Solomon, Richard W. Chapman, Robbie L. McLeod, Daniel Prelusky, Stephen Eckel, George Kelly, Michelle Natiello, Aileen House, Xiomara Fernandez, Rema Bitar, Jonathan E. Phillips, John C. Anthes	2011	15
18	Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Jonathan E. Phillips, Lorena Renteria, Lisa Burns, Paul G. Harris, Ruoqi Peng, Carla M. T. Bauer, Dramane I. Lainé, Christopher S. Stevenson	2016	14
19	Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity Sensors ·Seon‐Cheol Park, Narongkorn Saiphoklang, Dong‐Hyun Jung, David Gómez, Jonathan E. Phillips, Brett A. Dolezal, Donald P. Tashkin, Igor Barjaktarević, Christopher B. Cooper	2022	11
20	Bidirectional Transepithelial Water Transport: Chloride-Dependent Mechanisms The Journal of Membrane Biology ·Jonathan E. Phillips, Donovan B. Yeates	2000	11

About Jonathan E. Phillips

Jonathan E. Phillips is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Molecular Biology, Animal Science and Zoology and Oncology, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (18 papers), Inhalation and Respiratory Drug Delivery (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Phosphodiesterase function and regulation (6 papers), Pharmacological Effects and Assays (5 papers), Allergic Rhinitis and Sensitization (4 papers), Receptor Mechanisms and Signaling (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (520 citations), Physiology (337 citations), Immunology (257 citations), Immunology and Allergy (48 citations) and Oncology (193 citations). Jonathan E. Phillips has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Jay S. Fine, Richard W. Chapman, R. William Hipkin, Aidan K. Curran, D J Lundell, Donovan B. Yeates, John A. Hey, Christopher S. Stevenson, Ruoqi Peng and Gaurav Tyagi. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Pharmacology, Pharmacology & Therapeutics, Pulmonary Pharmacology & Therapeutics and Journal of Visualized Experiments.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact